Global Artificial Intelligence (AI) in Pharmaceutical Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08251824

Publication Date:

August 16, 2024

Pages:

111

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Artificial Intelligence (AI) in Pharmaceutical market size was valued at US$ million in 2023. With growing demand in downstream market, the Artificial Intelligence (AI) in Pharmaceutical is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Artificial Intelligence (AI) in Pharmaceutical market. Artificial Intelligence (AI) in Pharmaceutical are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Intelligence (AI) in Pharmaceutical. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Intelligence (AI) in Pharmaceutical market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Artificial Intelligence (AI) in Pharmaceutical market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artificial Intelligence (AI) in Pharmaceutical market. It may include historical data, market segmentation by Type (e.g., Hardware, Software), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Intelligence (AI) in Pharmaceutical market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Intelligence (AI) in Pharmaceutical market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artificial Intelligence (AI) in Pharmaceutical industry. This include advancements in Artificial Intelligence (AI) in Pharmaceutical technology, Artificial Intelligence (AI) in Pharmaceutical new entrants, Artificial Intelligence (AI) in Pharmaceutical new investment, and other innovations that are shaping the future of Artificial Intelligence (AI) in Pharmaceutical.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Intelligence (AI) in Pharmaceutical market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Intelligence (AI) in Pharmaceutical product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Intelligence (AI) in Pharmaceutical market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Intelligence (AI) in Pharmaceutical market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Intelligence (AI) in Pharmaceutical market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Intelligence (AI) in Pharmaceutical industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Intelligence (AI) in Pharmaceutical market.
Market Segmentation:
Artificial Intelligence (AI) in Pharmaceutical market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Hardware
Software
Segmentation by application
Pharmaceutical Company
Institute of Biology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca LLC
Atomwise Inc
Bayer AG
Cloud Pharmaceuticals Inc
GNS Healthcare
IBM Watson
Merck & Co.
Microsoft Corporation
Novartis AG
NVIDIA Corporation
Pfizer Inc.
Recursion Pharmaceuticals Inc.
XtalPi Inc

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size 2019-2030
2.1.2 Artificial Intelligence (AI) in Pharmaceutical Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Artificial Intelligence (AI) in Pharmaceutical Segment by Type
2.2.1 Hardware
2.2.2 Software
2.3 Artificial Intelligence (AI) in Pharmaceutical Market Size by Type
2.3.1 Artificial Intelligence (AI) in Pharmaceutical Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Market Share by Type (2019-2024)
2.4 Artificial Intelligence (AI) in Pharmaceutical Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Institute of Biology
2.4.3 Others
2.5 Artificial Intelligence (AI) in Pharmaceutical Market Size by Application
2.5.1 Artificial Intelligence (AI) in Pharmaceutical Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Market Share by Application (2019-2024)
3 Artificial Intelligence (AI) in Pharmaceutical Market Size by Player
3.1 Artificial Intelligence (AI) in Pharmaceutical Market Size Market Share by Players
3.1.1 Global Artificial Intelligence (AI) in Pharmaceutical Revenue by Players (2019-2024)
3.1.2 Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence (AI) in Pharmaceutical Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence (AI) in Pharmaceutical by Regions
4.1 Artificial Intelligence (AI) in Pharmaceutical Market Size by Regions (2019-2024)
4.2 Americas Artificial Intelligence (AI) in Pharmaceutical Market Size Growth (2019-2024)
4.3 APAC Artificial Intelligence (AI) in Pharmaceutical Market Size Growth (2019-2024)
4.4 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size Growth (2019-2024)
4.5 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size Growth (2019-2024)
5 Americas
5.1 Americas Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2019-2024)
5.2 Americas Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2019-2024)
5.3 Americas Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2019-2024)
6.2 APAC Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2019-2024)
6.3 APAC Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence (AI) in Pharmaceutical by Country (2019-2024)
7.2 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2019-2024)
7.3 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.1 Global Artificial Intelligence (AI) in Pharmaceutical Forecast by Regions (2025-2030)
10.1.1 Global Artificial Intelligence (AI) in Pharmaceutical Forecast by Regions (2025-2030)
10.1.2 Americas Artificial Intelligence (AI) in Pharmaceutical Forecast
10.1.3 APAC Artificial Intelligence (AI) in Pharmaceutical Forecast
10.1.4 Europe Artificial Intelligence (AI) in Pharmaceutical Forecast
10.1.5 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Forecast
10.2 Americas Artificial Intelligence (AI) in Pharmaceutical Forecast by Country (2025-2030)
10.2.1 United States Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.2.2 Canada Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.2.3 Mexico Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.2.4 Brazil Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.3 APAC Artificial Intelligence (AI) in Pharmaceutical Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.3.2 Japan Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.3.3 Korea Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.3.4 Southeast Asia Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.3.5 India Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.3.6 Australia Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.4 Europe Artificial Intelligence (AI) in Pharmaceutical Forecast by Country (2025-2030)
10.4.1 Germany Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.4.2 France Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.4.3 UK Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.4.4 Italy Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.4.5 Russia Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.5 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Forecast by Region (2025-2030)
10.5.1 Egypt Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.5.2 South Africa Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.5.3 Israel Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.5.4 Turkey Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.5.5 GCC Countries Artificial Intelligence (AI) in Pharmaceutical Market Forecast
10.6 Global Artificial Intelligence (AI) in Pharmaceutical Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence (AI) in Pharmaceutical Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 AstraZeneca LLC
11.1.1 AstraZeneca LLC Company Information
11.1.2 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.1.3 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca LLC Main Business Overview
11.1.5 AstraZeneca LLC Latest Developments
11.2 Atomwise Inc
11.2.1 Atomwise Inc Company Information
11.2.2 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.2.3 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Atomwise Inc Main Business Overview
11.2.5 Atomwise Inc Latest Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Information
11.3.2 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.3.3 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bayer AG Main Business Overview
11.3.5 Bayer AG Latest Developments
11.4 Cloud Pharmaceuticals Inc
11.4.1 Cloud Pharmaceuticals Inc Company Information
11.4.2 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.4.3 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Cloud Pharmaceuticals Inc Main Business Overview
11.4.5 Cloud Pharmaceuticals Inc Latest Developments
11.5 GNS Healthcare
11.5.1 GNS Healthcare Company Information
11.5.2 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.5.3 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GNS Healthcare Main Business Overview
11.5.5 GNS Healthcare Latest Developments
11.6 IBM Watson
11.6.1 IBM Watson Company Information
11.6.2 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.6.3 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 IBM Watson Main Business Overview
11.6.5 IBM Watson Latest Developments
11.7 Merck & Co.
11.7.1 Merck & Co. Company Information
11.7.2 Merck & Co. Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.7.3 Merck & Co. Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Merck & Co. Main Business Overview
11.7.5 Merck & Co. Latest Developments
11.8 Microsoft Corporation
11.8.1 Microsoft Corporation Company Information
11.8.2 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.8.3 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Microsoft Corporation Main Business Overview
11.8.5 Microsoft Corporation Latest Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Information
11.9.2 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.9.3 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novartis AG Main Business Overview
11.9.5 Novartis AG Latest Developments
11.10 NVIDIA Corporation
11.10.1 NVIDIA Corporation Company Information
11.10.2 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.10.3 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 NVIDIA Corporation Main Business Overview
11.10.5 NVIDIA Corporation Latest Developments
11.11 Pfizer Inc.
11.11.1 Pfizer Inc. Company Information
11.11.2 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.11.3 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Pfizer Inc. Main Business Overview
11.11.5 Pfizer Inc. Latest Developments
11.12 Recursion Pharmaceuticals Inc.
11.12.1 Recursion Pharmaceuticals Inc. Company Information
11.12.2 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.12.3 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Recursion Pharmaceuticals Inc. Main Business Overview
11.12.5 Recursion Pharmaceuticals Inc. Latest Developments
11.13 XtalPi Inc
11.13.1 XtalPi Inc Company Information
11.13.2 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Product Offered
11.13.3 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 XtalPi Inc Main Business Overview
11.13.5 XtalPi Inc Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂